Managers / Q1 2025 · view latest →
Carlson Capital, L.P.
CIK 0001056973 · 2100 MCKINNEY AVE, STE 1900, DALLAS, TX, 75201 · 2149329600
Summary
Carlson Capital, L.P. reported $256M in U.S.-listed holdings across 40 positions for Q1 2025.
The portfolio is heavily concentrated: SWKH alone accounts for 57.7% of reported value.
Compared with Q4 2024, the fund opened 23 new positions and exited 16.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 73.1% · $187M
- ETP · 26.8% · $69M
- Other · 0.1% · $242,400
Quarter-over-Quarter Changes full breakdown →
vs Q4 2024 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| TSLATESLA INC | NEW | +12.0K | 12.0K | +$3M | $3M |
| ITCIEURINTRA-CELLULAR THERAPIES INC | NEW | +23.0K | 23.0K | +$3M | $3M |
| SOFISOFI TECHNOLOGIES INC | NEW | +250.0K | 250.0K | +$3M | $3M |
| AFRMAFFIRM HLDGS INC | NEW | +30.0K | 30.0K | +$1M | $1M |
| HALHALLIBURTON CO | NEW | +42.4K | 42.4K | +$1M | $1M |
| XXYCROSS CTRY HEALTHCARE INC | NEW | +70.0K | 70.0K | +$1M | $1M |
| AKXANSYS INC | NEW | +3.1K | 3.1K | +$981,336 | $981,336 |
| CMRXEURCHIMERIX INC | NEW | +114.0K | 114.0K | +$970,140 | $970,140 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2025
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | SWKHSWK HLDGS CORPhistory → | COM NEW | 57.65% | $148M | 8.49M |
| 2 | HESHESS CORPhistory → | COM | 1.37% | $4M | 22.0K |
| 3 | DFSEURDISCOVER FINL SVCShistory → | COM | 1.37% | $3M | 20.5K |
| 4 | ITCIEURINTRA-CELLULAR THERAPIES INChistory → | COM | 1.18% | $3M | 23.0K |
| 5 | KELKELLANOVAhistory → | COM | 1.00% | $3M | 31.1K |
| 6 | PNCPNC FINL SVCS GROUP INC | COM | 0.48% | $1M | 7.0K |
| 7 | HALHALLIBURTON CO | COM | 0.42% | $1M | 42.4K |
| 8 | XXYCROSS CTRY HEALTHCARE INC | COM | 0.41% | $1M | 70.0K |
| 9 | AKXANSYS INC | COM | 0.38% | $981,336 | 3.1K |
| 10 | CMRXEURCHIMERIX INC | COM | 0.38% | $970,140 | 114.0K |
| 11 | APY1EURCHAMPIONX CORPORATION | COM | 0.37% | $953,600 | 32.0K |
| 12 | STTSTATE STR CORP | COM | 0.37% | $940,065 | 10.5K |
| 13 | FITBFIFTH THIRD BANCORP | COM | 0.29% | $752,640 | 19.2K |
| 14 | EXMOCEXXON MOBIL CORP | COM | 0.29% | $749,259 | 6.3K |
| 15 | BACBANK AMERICA CORP | COM | 0.29% | $746,967 | 17.9K |
| 16 | FAFFIRST AMERN FINL CORP | COM | 0.25% | $630,048 | 9.6K |
| 17 | ACIALBERTSONS COS INC | COMMON STOCK | 0.24% | $604,725 | 27.5K |
| 18 | DLTRDOLLAR TREE INC | COM | 0.23% | $585,546 | 7.8K |
| 19 | BOKFBOK FINL CORP | COM NEW | 0.23% | $583,240 | 5.6K |
| 20 | MAGNMAGNERA CORP | COM SHS | 0.23% | $582,936 | 32.1K |
| 21 | FANGDIAMONDBACK ENERGY INC | COM | 0.22% | $575,568 | 3.6K |
| 22 | SYU1SYNOVUS FINL CORP | COM NEW | 0.21% | $532,836 | 11.4K |
| 23 | AMTMAMENTUM HOLDINGS INC | COM | 0.20% | $509,600 | 28.0K |
| 24 | CSXCSX CORP | COM | 0.20% | $500,310 | 17.0K |
| 25 | GPNGLOBAL PMTS INC | COM | 0.19% | $489,600 | 5.0K |
| 26 | USBUS BANCORP DEL | COM NEW | 0.18% | $455,976 | 10.8K |
| 27 | COPCONOCOPHILLIPS | COM | 0.18% | $451,586 | 4.3K |
| 28 | SSBUSDSOUTHSTATE CORPORATION | COM | 0.16% | $408,408 | 4.4K |
| 29 | NTRSNORTHERN TR CORP | COM | 0.16% | $404,465 | 4.1K |
| 30 | CARRCARRIER GLOBAL CORPORATION | COM | 0.15% | $380,400 | 6.0K |
| 31 | GOOGALPHABET INC | CAP STK CL C | 0.14% | $359,329 | 2.3K |
| 32 | LOWLOWES COS INC | COM | 0.14% | $349,845 | 1.5K |
| 33 | CYTKCYTOKINETICS INC | COM NEW | 0.12% | $301,425 | 7.5K |
| 34 | DECKDECKERS OUTDOOR CORP | COM | 0.11% | $279,525 | 2.5K |
| 35 | CHECKPOINT THERAPEUTICS INC | COM NEW | 0.09% | $242,400 | 60.0K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $318M | 72 | May 28, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $282M | 70 | Feb 3, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $271M | 63 | Nov 5, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $242M | 65 | Aug 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $256M | 40 | May 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $170M | 33 | Feb 5, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $166M | 4 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $641M | 93 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $1.2B | 114 | May 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $1.3B | 121 | Feb 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $1.3B | 134 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $1.2B | 118 | Aug 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $1.1B | 110 | May 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $1.3B | 117 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $1.3B | 120 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $1.5B | 124 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $1.5B | 151 | May 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $1.7B | 144 | Feb 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $1.9B | 161 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $2.1B | 152 | Aug 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $2.7B | 169 | May 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $2.8B | 152 | Feb 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020REVEALED | $6.8B | 341 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $3.6B | 162 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $3.8B | 210 | May 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $5.5B | 240 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $5.5B | 224 | Nov 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $6.6B | 250 | Aug 12, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $5.6B | 242 | May 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $6.5B | 266 | Feb 13, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.